Literature DB >> 3389336

The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis.

U Berger1, R Bettelheim, J L Mansi, D Easton, R C Coombes, A M Neville.   

Abstract

The pathologic features of the primary tumors in 285 patients with breast cancer at the time of initial presentation, and with no clinical evidence of distant metastases, have been analyzed. The results have been compared with the detection of tumor cells in the bone marrow by use of an immunocytochemical method using antisera raised against the epithelial membrane antigen (EMA). The authors found EMA-positive cells (i.e., tumor cells) in the bone marrow of 77 (27%) patients and a significant association between the presence of such EMA-positive cells in the bone marrow and tumor size (P = 0.006) and peritumoral vascular invasion (P = less than 0.001). A possible relationship with estrogen receptor negativity (P = 0.06) also was noted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389336     DOI: 10.1093/ajcp/90.1.1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

Review 1.  The basic pathology of human breast cancer.

Authors:  E Mallon; P Osin; N Nasiri; I Blain; B Howard; B Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

Review 2.  Dose-intensified treatment of breast cancer: current results.

Authors:  C von Schilling; F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

Review 3.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 4.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

Review 5.  Micrometastatic bone marrow involvement: detection and prognostic significance.

Authors:  S Braun; K Pantel
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

Review 6.  The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

Authors:  Heike Allgayer; Julio A Aguirre-Ghiso
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

7.  Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study.

Authors:  Annamaria Molino; Monica Giovannini; Rocco Micciolo; Alessandra Auriemma; Elena Fiorio; Antonio Santo; Gian Luigi Cetto
Journal:  Clin Med Oncol       Date:  2008-09-04

8.  p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.

Authors:  T Unger; M M Nau; S Segal; J D Minna
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

9.  Increased expression of differentiation markers can accompany laminin-induced attachment of small cell lung cancer cells.

Authors:  G Giaccone; J Broers; S Jensen; R I Fridman; R Linnoila; A F Gazdar
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

10.  Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.

Authors:  C Natoli; C Garufi; N Tinari; M D'Egidio; G Lesti; L A Gaspari; R Visini; S Iacobelli
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.